Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease

NCT04344444 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

22

Enrollment

OTHER

Sponsor class

Stopped Lack of efficacy data from other studies

Conditions

COVID-19

Interventions

DRUG: Hydroxychloroquine
DRUG: Azithromycin

Sponsor

LCMC Health